Medical Research News

RSS

Study finds indoor cats do not trigger child asthma flares

Asthma is the most common chronic disease and one of the main causes of hospitalization among children. The Global Asthma Network has estimated that its global prevalence is 9.1% for children and 11.0% for adolescents, but this percentage varies greatly between countries, regions, and environments.

10 Jun 2026

GLP-1 medicines may cut clot-related risks in chronically inflamed patients

In a target trial emulation using OneFlorida+ electronic health record data, GLP-1 receptor agonist use in adults with obesity and autoimmune disease was linked to lower hazards of pulmonary embolism, venous thromboembolism, stroke/TIA, emergency department visits, and all-cause mortality.

10 Jun 2026

Fertility challenges may influence children's behavioral and developmental outcomes

Difficulty conceiving a pregnancy may be associated with small differences in children's learning and behavior, according to a new study funded by the Environmental influences on Child Health Outcomes (ECHO) Program at the National Institutes of Health (NIH).

9 Jun 2026

Oral swab detects hidden inflammation in rare lung disease

Researchers at UTHealth Houston have identified different types of hidden systemic inflammation in patients with primary ciliary dyskinesia, even when they are not experiencing acute illness.

9 Jun 2026

Limited screen use may support concussion recovery process

Moderate screen time in the first 3 days after concussion is linked to faster recovery, with an average 141 minutes of daily use speeding up symptom resolution by 35%, finds a study of 80 concussed teens published online in the British Journal of Sports Medicine.

9 Jun 2026

Food security review shows how countries can protect staple crops from global shocks

A systematic review of 105 studies found that climate change, water scarcity, land-use change, biofuel demand, trade disruptions, pandemics and conflict are major threats to maize, rice and wheat supplies. The authors identify international trade, agricultural innovation, virtual water trading and well-managed food stockpiles as practical ways to strengthen food security.

9 Jun 2026

Mycoplasma genitalium unlikely to drive recurrent preterm deliveries

A new study from UTHealth Houston found that the common sexually transmitted infection, Mycoplasma genitalium, also known as MGen, does not appear to increase the risk of recurrent preterm birth.

9 Jun 2026

New meningioma atlas uncovers clues to tumor aggressiveness

One of the most detailed maps to date of meningioma - the most common brain tumor in adults - reveals how the tumor's surrounding environment helps drive disease behavior and patient outcomes, according to new research from Mayo Clinic.

9 Jun 2026

NHS pathology staff face unsafe formaldehyde exposure levels

Routine exposure to harmful levels of the human tissue preservative formaldehyde are risking the health of thousands of NHS staff working in pathology departments across the UK, due to poor monitoring and control, finds an analysis of Freedom of Information (FOI) requests, published online in the journal Occupational & Environmental Medicine.

9 Jun 2026

Moderate screen exposure linked to better concussion outcomes

Researchers at Nationwide Children's Hospital have found that moderate screen time might be better for concussion recovery than no screen time at all.

9 Jun 2026

Statins may help prevent frailty in older adults

Researchers at Mass General Brigham have demonstrated that older U.S. veterans who initiated statin therapy were significantly less likely to develop frailty over time, suggesting that the cholesterol-lowering medications may have healthy aging benefits beyond cardiovascular disease prevention. Results are published in the European Heart Journal.

9 Jun 2026

Apitegromab helps tirzepatide users lose fat while preserving lean mass

A phase 2 trial found that apitegromab plus tirzepatide reduced lean body mass loss by 1.9 kg compared with tirzepatide plus placebo after 24 weeks, while overall weight loss remained similar.

9 Jun 2026

Obesity drug mazdutide reduces weight and waist size in major trial

Once-weekly 9 mg mazdutide produced clinically meaningful weight loss in Chinese adults with obesity, reducing body weight by 16.65% after 60 weeks versus 1.50% with placebo. The phase 3 GLORY-2 trial also found improvements in waist circumference, systolic blood pressure, and lipid markers, but gastrointestinal adverse events were common.

9 Jun 2026